The Environment for Health Care Decision-making: Collecting, Using and Understanding Comparative Effectiveness Research

Track:
Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)

Day & Time:
June 26, 8:00AM - 9:30AM

Session Number:
317

Room Number:
151B

Level:
Intermediate

Type:
Session

Title:
The Environment for Health Care Decision-making: Collecting, Using and Understanding Comparative Effectiveness Research

Chair(s):
Kimberly Westrich, MA
Director, Health Services Research
National Pharmaceutical Council, United States

Description:
This session will provide an overview of how stakeholders view the environment for health care decision-making, an in-depth look at how payers view and use comparative effectiveness research (CER) studies for these decisions, and an innovative way to collect the patient data needed for these CER studies.

Learning Objective(s):
Describe stakeholder views on the impact of comparative effectiveness research (CER) for health care decision-making; Discuss how payers consider and use CER to make decisions; Define models for collection of real-world, observational data directly through patients.

Presentation(s) & Speaker(s):
Monitoring Changes in the Environment for Health Care Decision-making
Kimberly Westrich, MA
Director, Health Services Research
National Pharmaceutical Council, United States

Translating CER into Medical Payment Policy: Views from Public and Private Payers
Joel S. Weissman, PhD
Associate Professor, Health Policy
Harvard Medical School, United States

Working Directly with Patients to Collect HEO/CER Data Using Innovative Hybrid Observational Research Models
John Reites
Director, Operations
Quintiles Inc., United States